Effectiveness, Safety, and Costs of a Treatment Switch to Dolutegravir Plus Rilpivirine Dual Therapy in Treatment-Experienced HIV Patients.
about
Dolutegravir plus rilpivirine dual therapy in treating HIV-1 infection.Effectiveness, Safety, and Tolerability of a Switch to Dual Therapy with Dolutegravir Plus Cobicistat-Boosted Darunavir in Treatment-Experienced Patients with Human Immunodeficiency VirusVirologic failure and HIV drug resistance on simplified, dolutegravir-based maintenance therapy: Systematic review and meta-analysis
P2860
Effectiveness, Safety, and Costs of a Treatment Switch to Dolutegravir Plus Rilpivirine Dual Therapy in Treatment-Experienced HIV Patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Effectiveness, Safety, and Cos ...... ment-Experienced HIV Patients.
@en
type
label
Effectiveness, Safety, and Cos ...... ment-Experienced HIV Patients.
@en
prefLabel
Effectiveness, Safety, and Cos ...... ment-Experienced HIV Patients.
@en
P2093
P2860
P356
P1476
Effectiveness, Safety, and Cos ...... tment-Experienced HIV Patients
@en
P2093
Carmen Guadalupe Rodríguez-González
Esther Chamorro-de-Vega
María Sanjurjo-Sáez
Roberto Alonso
P2860
P356
10.1177/1060028017728294
P407
P577
2017-08-24T00:00:00Z